Xencor
XNCR
#6099
Rank
โ‚ฌ0.76 B
Marketcap
10,50ย โ‚ฌ
Share price
3.36%
Change (1 day)
-11.99%
Change (1 year)

Earnings for Xencor (XNCR)

Earnings in 2025 (TTM): -โ‚ฌ0.13 Billion

According to Xencor's latest financial reports the company's current earnings are โ‚ฌ0.16 Billion. In 2024 the company made an earning of -โ‚ฌ0.22 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Xencor from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.13 Billion-40.4%
2024 -โ‚ฌ0.22 Billion101.73%
2023 -โ‚ฌ0.11 Billion120.95%
2022 -โ‚ฌ47.69 Million-165.97%
2021 โ‚ฌ72.29 M-219.18%
2020 -โ‚ฌ60.66 Million-355.02%
2019 โ‚ฌ23.78 M-138.61%
2018 -โ‚ฌ61.61 Million21.07%
2017 -โ‚ฌ50.89 Million-336.25%
2016 โ‚ฌ21.53 M-239.93%
2015 -โ‚ฌ15.4 Million7.12%
2014 -โ‚ฌ14.37 Million-72.75%
2013 -โ‚ฌ52.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.34 B-23,576.55%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ1.45 B-1,302.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.21 B-6,074.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ20.20 B-16,832.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚ฌ0.7 Billion 472.91%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
-โ‚ฌ65.48 Million-45.77%๐Ÿ‡บ๐Ÿ‡ธ USA